Insider · CIK 0001421339
Richard R. DeLuca
officer
Files at MRK (Merck & Co., Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 29, 2025 | MRK Merck & Co., Inc. | AGrant or award Restricted Stock Unitderivative | +7,555 | $0.00 | $0 | 7,555 | May 1, 2025 |
| Apr 29, 2025 | MRK Merck & Co., Inc. | AGrant or award Stock Option (Right to Buy)derivative | +34,390 | $0.00 | $0 | 34,390 | May 1, 2025 |
| Jan 27, 2025 | MRK Merck & Co., Inc. | AGrant or award Common Stock | +25,438 | $97.94 | $2.5M | 178,993 | Jan 29, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.